M
Morgenstern Kurt A
Researcher at Vertex Pharmaceuticals
Publications - 12
Citations - 1997
Morgenstern Kurt A is an academic researcher from Vertex Pharmaceuticals. The author has contributed to research in topics: Protease & NS3. The author has an hindex of 9, co-authored 12 publications receiving 1976 citations.
Papers
More filters
Journal ArticleDOI
Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.
Joseph L. Kim,Morgenstern Kurt A,Chao Lin,Ted Fox,Maureen D. Dwyer,J. A. Landro,Stephen P. Chambers,William Markland,Christopher A. Lepre,Ethan O'malley,Scott L. Harbeson,Charles M. Rice,Murcko Mark A,Paul R. Caron,John A. Thomson +14 more
TL;DR: The 2.5 angstrom resolution X-ray crystal structure of the NS3 protease domain complexed with a synthetic NS4A activator peptide is reported, which shows a chymotrypsin-like fold and features a tetrahedrally coordinated metal ion distal to the active site.
Journal ArticleDOI
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
Joseph L. Kim,Morgenstern Kurt A,James P. Griffith,Maureen D. Dwyer,John A. Thomson,Murcko Mark A,Chao Lin,Paul R. Caron +7 more
TL;DR: The structure of the HCV NS3 RNA helicase domain complexed with a single-stranded DNA oligonucleotide has been solved to 2.2 A resolution and is a member of a superfamily of helicases, termed superfamily II.
Journal ArticleDOI
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors
Xiaotian Zhu,Joseph L. Kim,John Newcomb,Paul E. Rose,David R Stover,Leticia M Toledo,Huilin Zhao,Morgenstern Kurt A +7 more
TL;DR: High-resolution crystal structures of an activated Lck kinase domain in complex with three structurally distinct ATP-competitive inhibitors demonstrate that kinase selectivity can be achieved with small-molecule inhibitors that exploit subtle topological differences among protein kinases.
Journal ArticleDOI
Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
J. A. Landro,Scott A. Raybuck,Yu Ping C. Luong,Ethan O'malley,Scott L. Harbeson,Morgenstern Kurt A,Govinda Rao,David J. Livingston +7 more
TL;DR: This result suggests that NS4A does not change the pKa values of the active site residues of NS3 protease, and shows a marked catalytic preference for the cysteine residue commonly found in authentic substrates.
Journal ArticleDOI
Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells.
TL;DR: It is suggested that the domains within NS3 may influence the activity of one another and that the interplay of HCV genomic elements may regulate the enzyme activities of this complex HCV replicase component.